Intravitreal aflibercept for neovascular AMD in the very elderly neovascular AMD patients: UK Multi-centre Real World Outcome

被引:0
|
作者
Talks, James [1 ]
Sivaprasad, Sobha [2 ]
机构
[1] Newcastle Upon Tyne Hosp NHS Fdn Trust, Ctr Eye, Newcastle Upon Tyne, Tyne & Wear, England
[2] Moorfields Eye Hosp, London, England
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
911
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Vertical metamorphopsia improved in patients treated with Aflibercept for neovascular AMD at eighteen months follow-up.
    Schroeder, Marion
    Loevestam-Adrian, Monica
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [32] Intravitreal aflibercept (A-IVI) for the treatment of neovascular age related macular degeneration (nv-AMD): one year experience
    Papavasileiou, Evangelia
    Zygoura, Vasiliki
    Richardson, Theresa
    Cortis, Dominic
    Eleftheriadis, Haralabos
    Jackson, Timothy L.
    [J]. HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2015, 18 (03): : 29 - 32
  • [33] Faricimab in neovascular AMD: first report of real-world outcomes in an independent retina clinic
    Paulo Eduardo Stanga
    Francisco Javier Valentín-Bravo
    Sebastian Eduardo Francis Stanga
    Ursula Inge Reinstein
    Salvador Pastor-Idoate
    Susan M. Downes
    [J]. Eye, 2023, 37 : 3282 - 3289
  • [34] Faricimab in neovascular AMD: first report of real-world outcomes in an independent retina clinic
    Stanga, Paulo Eduardo
    Valentin-Bravo, Francisco Javier
    Stanga, Sebastian Eduardo Francis
    Reinstein, Ursula Inge
    Pastor-Idoate, Salvador
    Downes, Susan M.
    [J]. EYE, 2023, 37 (15) : 3282 - 3289
  • [35] Characterizing Progression to Neovascular AMD in Fellow Eyes of Patients Treated With Intravitreal Anti-VEGF Injections
    Starr, Matthew R.
    Xu, David
    Boucher, Nicholas
    Saroj, Namrata
    Patel, Luv G.
    Ammar, Michael
    Pandit, Ravi R.
    Jenkins, Thomas L.
    Ho, Allen C.
    [J]. OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2021, 52 (03): : 123 - 128
  • [36] Adherence to treatment determines 5-year outcome in neovascular AMD in a real-life setting
    Wilke, Robert G. H.
    Sachs, Helmut G.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [37] Recurrence of neovascular (wet) age-related macular degeneration (AMD) in patients discharged from care in a real-world clinical practice in the UK
    Alfaqawi, Fadi
    Elsherbiny, Samer
    Mushtaq, Bushra
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [38] Real-World Treatment Patterns in a Population With Neovascular AMD Treated With Anti-VEGF Agents
    Urbano, Catherine A.
    Maatouk, Christopher
    Greenlee, Tyler
    Chen, Andrew
    Conti, Thais F.
    Briskin, Isaac
    Singh, Rishi P.
    [J]. OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2021, 52 (04): : 190 - 198
  • [39] FREQUENCY OF INTRAVITREAL INJECTIONS POST CATARACT SURGERY IN PATIENTS RECEIVING ANTI-VEGF TREATMENT FOR NEOVASCULAR AMD
    Enright, Nicholas J.
    McGuinness, Myra B.
    Parikh, Sumit
    Fotis, Kathy
    Guymer, Robyn H.
    Sandhu, Sukhpal S.
    Finger, Robert P.
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 44 : 132 - 132
  • [40] Psychophysical, electrofunctional, and morphological evaluation in naïve neovascular AMD patients treated with intravitreal anti-VEGF
    Nebbioso, Marcella
    Franzone, Federica
    Milanese, Alberto
    Artico, Marco
    Taurone, Samanta
    La Cava, Maurizio
    Livani, Maria Luisa
    Bonfiglio, Vincenza
    Vestri, Annarita
    [J]. AGING MEDICINE, 2024, 7 (02) : 189 - 201